Transactional Content Management

PRODUCTS

  • Gain human-relevant insights with patient-derived assay-ready organoids.

  • There are clearly defined pathways for drug approval, and choosing the right regulatory pathway for your drug development program requires a thorough understanding of sections 505(b)(1) and 505(b)(2) of the Federal Food, Drug, and Cosmetics (FD&C) Act.

  • Are you in need of an experienced and flexible GMP service provider that can assist you with the development and clinical manufacturing of your gene or cell therapy with expert CMC support?

  • Expediting the customer journey from discovery all the way through commercial release.

  • Global Strategies to Align Your Goals With Regulatory Requirements

    Ergomed’s regulatory consultancy services are guided by a team of seasoned consultants, each bringing a wealth of experience from regulatory agencies and in-house roles. This expertise ensures a proactive and flexible solution tailored to your project’s unique needs and timelines, instilling confidence in our services.

WHITE PAPERS AND CASE STUDIES

NEWS